Causes and Characteristics of Diabetic Cardiomyopathy

Review

Rev Diabet Stud, 2006, 3(3):108-117

DOI 10.1900/RDS.2006.3.108

Causes and Characteristics of Diabetic Cardiomyopathy

Jianxun Wang¹, Ye Song², Qianwen Wang³, Patricia M. Kralik², Paul N. Epstein²

¹Departments of Pharmacology and Toxicology, University of Louisville, Louisville, KY 40202, USA.
²Department of Pediatrics, University of Louisville, Louisville, KY 40202, USA.
³Department of Physiology and Biophysics, University of Louisville, Louisville, KY 40202, USA.
Address correspondence to: Paul N. Epstein, e-mail: paul.epstein@louisville.edu

Keywords: diabetes, cardiomyopathy, coronary artery disease, obesity, hyperglycemia, insulin, angiotensin

Abstract (FREE). Full-text access requires a subscription to The Review of Diabetic Studies.

To view full-text, select one of the options below:

Login if you are subscriber:

Purchase short-term access:

Username

Pay per Article for 1 day for EUR 25.00.
Pay for Admission to all content in The Review of Diabetic Studies for 5 days for EUR 40.00.
Regain Access - You can regain access to a recent Pay per Article or Pay for Admission purchase if your access period has not yet expired.

Password

Having trouble logging in? Be sure to enable cookies in your web browser.

Forgot your user name or password?

Sign in for subscription:

Subscribe to the journal.

This article has been cited by other articles:

	Emerging role of epigenetics and miRNA in diabetic cardiomyopathy Asrih M, Steffens S Cardiovasc Pathol 2012. Epub

	Nox4-derived reactive oxygen species mediate cardiomyocyte injury in early type 1 diabetes Maalouf RM, Eid AA, Gorin YC, Block K, Escobar GP, Bailey S, Abboud HE Am J Physiol Cell Physiol 2012. 302(3):C597-C604

	Particulate matter exposure exacerbates high glucose-induced cardiomyocyte dysfunction through ROS generation Zuo L, Youtz DJ, Wold LE PLoS One 2011. 6(8):e23116

	Berberine attenuates cardiac dysfunction in hyperglycemic and hypercholesterolemic rats Dong SF, Hong Y, Liu M, Hao YZ, Yu HS, Liu Y, Sun JN Eur J Pharmacol 2011. 660(2-3):368-374

	Potential role of nuclear factor kappaB in diabetic cardiomyopathy Lorenzo O, Picatoste B, Ares-Carrasco S, Ramirez E, Egido J, Tunon J Mediators Inflamm 2011. 2011:652097

	Peroxisome proliferator-activated receptors, metabolic syndrome and cardiovascular disease Azhar S Future Cardiol 2010. 6(5):657-691

	Maternal obesity induces fibrosis in fetal myocardium of sheep Huang Y, Yan X, Zhao JX, Zhu MJ, McCormick RJ, Ford SP, Nathanielsz PW, Ren J, Du M Am J Physiol Endocrinol Metab 2010. 299(6):E968-E975

	The absence of pathological myofibre disarray in the diabetic heart: is it a paradox? McLachlan CS, Lasker S, Keramat SM, Wang L, Jelinek H Acta Cardiol 2009. 64(2):267-268

	Shotgun Lipidomics of Neutral Lipids as an Enabling Technology for Elucidation of Lipid-Related Diseases Gross RW, Han X Am J Physiol Endocrinol Metab 2009. 297(2):E297-E303

	Animal models of diabetes mellitus: relevance to vascular complications Thompson CS Curr Pharm Des 2008. 14(4):309-324

	Cod liver oil supplementation improves cardiovascular and metabolic abnormalities in streptozotocin diabetic rats Ceylan-Isik A, Hünkar T, Asan E, Kaymaz F, Ari N, Söylemezoglu T, Renda N, Soncul H, Bali M, Karasu C; The ADIC Study Group J Pharm Pharmacol 2007. 59(12):1629-1641

	Diabetic Cardiomyopathy in OVE26 Mice Shows Mitochondrial ROS Production and Divergence Between In Vivo and In Vitro Contractility Song Y, Du Y, Prabhu SD, Epstein PN Rev Diabet Stud 2007. 4(3):159-168